お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:臨床試験の世界市場 (2021-2027年):市場予測 (フェーズ・試験設計・治療分野別)・産業動向・地域的展望・用途の潜在性・価格動向・市場シェア
市場調査レポート
商品コード
1000736

臨床試験の世界市場 (2021-2027年):市場予測 (フェーズ・試験設計・治療分野別)・産業動向・地域的展望・用途の潜在性・価格動向・市場シェア

Clinical Trials Market Size By Phases, By Study Design, By Therapeutic Area, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027

出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 150 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.22円
臨床試験の世界市場 (2021-2027年):市場予測 (フェーズ・試験設計・治療分野別)・産業動向・地域的展望・用途の潜在性・価格動向・市場シェア
出版日: 2021年04月14日
発行: Global Market Insights Inc.
ページ情報: 英文 150 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

臨床試験の市場は慢性疾患の増加、FDAによる規制の強化、さまざまな疾患に対する新しい治療法の発見に向けた継続的な取り組みなどにより、今後数十年で大幅な成長を示すと予測されています。

フェーズ別では、フェーズIVの部門が2020年に79億ドル超を示し、予測期間中も早い速度で成長すると予測されています。また、試験設計別では、介入研究の部門が2020年に77.4%の市場シェアを示しており、今後も高い成長が見込まれています。さらに、治療分野別では、眼科部門が2027年末に約39億ドルの規模を示すと予測されています。

当レポートでは、世界の臨床試験の市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、市場規模の推移・予測、フェーズ・試験設計・治療分野・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 調査手法

第2章 エグゼクティブサマリー

第3章 産業考察

  • 産業の分類
  • 産業情勢
  • 産業への影響要因
    • 成長要因
    • 潜在的リスク&課題
  • 成長の可能性
  • COVID-19:影響分析
  • ポーターの分析
  • 競合情勢
  • PESTEL分析

第4章 市場分析・予測:フェーズ別

  • フェーズI
  • フェーズII
  • フェーズIII
  • フェーズIV

第5章 市場分析・予測:試験設計別

  • 介入研究
  • 観察研究
  • 拡大アクセス研究

第6章 市場分析・予測:治療分野別

  • 自己免疫疾患
  • 腫瘍
  • 心臓
  • 感染症
  • 皮膚科
  • 眼科
  • その他

第7章 市場分析・予測:地域・主要国別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第8章 企業プロファイル

  • 競合ダッシュボード
  • Bioclinica
  • ICON plc
  • Laboratory Corporation of American Holding (Covance Inc)
  • Medpace, Inc
  • Pharmaceutical Product Development, LLC (PPD)
  • PRA Health Sciences
  • WuXi AppTec
  • Parexel International Corporation
  • Charles River Laboratories (MPI Research)
  • Apex Medical Research
  • IQVIA
図表

Data Tables

  • TABLE 1 Global clinical trials market, 2016 - 2020 (USD Million)
  • TABLE 2 Global clinical trials market, 2021 - 2027 (USD Million)
  • TABLE 3 Global clinical trials market, by phases, 2016 - 2020 (USD Million)
  • TABLE 4 Global clinical trials market, by phases, 2021- 2027 (USD Million)
  • TABLE 5 Global clinical trials market, by study design, 2016 - 2020 (USD Million)
  • TABLE 6 Global clinical trials market, by study design, 2021- 2027 (USD Million)
  • TABLE 7 Global clinical trials market, by therapeutic area, 2016 - 2020 (USD Million)
  • TABLE 8 Global clinical trials market, by therapeutic area, 2021- 2027 (USD Million)
  • TABLE 9 Global clinical trials market, by region, 2016 - 2020 (USD Million)
  • TABLE 10 Global clinical trials market, by region, 2021 - 2027 (USD Million)
  • TABLE 11 Industry impact forces
  • TABLE 12 Phase I market size, by region, 2016 - 2020 (USD Million)
  • TABLE 13 Phase I market size, by region, 2021 - 2027 (USD Million)
  • TABLE 14 Phase II market size, by region, 2016 - 2020 (USD Million)
  • TABLE 15 Phase II market size, by region, 2021 - 20207 (USD Million)
  • TABLE 16 Phase III market size, by region, 2016 - 2020 (USD Million)
  • TABLE 17 Phase III market size, by region, 2021 - 2027 (USD Million)
  • TABLE 18 Phase IV market size, by region, 2016 - 2020 (USD Million)
  • TABLE 19 Phase IV market size, by region, 2021 - 2027 (USD Million)
  • TABLE 20 Interventional study market size, by region, 2016 - 2020 (USD Million)
  • TABLE 21 Interventional study market size, by region, 2021 - 2027 (USD Million)
  • TABLE 22 Observational study market size, by region, 2016 - 2020 (USD Million)
  • TABLE 23 Observational study market size, by region, 2021 - 2027 (USD Million)
  • TABLE 24 Expanded access study market size, by region, 2016 - 2020 (USD Million)
  • TABLE 25 Expanded access study market size, by region, 2021 - 2027 (USD Million)
  • TABLE 26 Autoimmune disease market size, by region, 2016 - 2020 (USD Million)
  • TABLE 27 Autoimmune disease market size, by region, 2021 - 2027 (USD Million)
  • TABLE 28 Oncology market size, by region, 2016 - 2020 (USD Million)
  • TABLE 29 Oncology market size, by region, 2021 - 20207 (USD Million)
  • TABLE 30 Cardiology market size, by region, 2016 - 2020 (USD Million)
  • TABLE 31 Cardiology market size, by region, 2021 - 2027 (USD Million)
  • TABLE 32 Infectious disease market size, by region, 2016 - 2020 (USD Million)
  • TABLE 33 Infectious disease market size, by region, 2021 - 2027 (USD Million)
  • TABLE 34 Dermatology market size, by region, 2016 - 2020 (USD Million)
  • TABLE 35 Dermatology market size, by region, 2021 - 2027 (USD Million)
  • TABLE 36 Ophthalmology market size, by region, 2016 - 2020 (USD Million)
  • TABLE 37 Ophthalmology market size, by region, 2021 - 2027 (USD Million)
  • TABLE 38 Others market size, by region, 2016 - 2020 (USD Million)
  • TABLE 39 Others market size, by region, 2021 - 2027 (USD Million)
  • TABLE 40 North America clinical trials market size, by country, 2016 - 2020 (USD Million)
  • TABLE 41 North America clinical trials market size, by country, 2021- 2027 (USD Million)
  • TABLE 42 North America clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 43 North America clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 44 North America clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 45 North America clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 46 North America clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 47 North America clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 48 U.S. clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 49 U.S. clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 50 U.S. clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 51 U.S. clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 52 U.S. clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 53 U.S. clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 54 Canada clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 55 Canada clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 56 Canada clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 57 Canada clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 58 Canada clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 59 Canada clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 60 Europe clinical trials market size, by country, 2016 - 2020 (USD Million)
  • TABLE 61 Europe clinical trials market size, by country, 2021- 2027 (USD Million)
  • TABLE 62 Europe clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 63 Europe clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 64 Europe clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 65 Europe clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 66 Europe clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 67 Europe clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 68 Germany clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 69 Germany clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 70 Germany clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 71 Germany clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 72 Germany clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 73 Germany clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 74 UK clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 75 UK clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 76 UK clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 77 UK clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 78 UK clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 79 UK clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 80 France clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 81 France clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 82 France clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 83 France clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 84 France clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 85 France clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 86 Italy clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 87 Italy clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 88 Italy clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 89 Italy clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 90 Italy clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 91 Italy clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 92 Spain clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 93 Spain clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 94 Spain clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 95 Spain clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 96 Spain clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 97 Spain clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 98 Asia Pacific clinical trials market size, by country, 2016 - 2020 (USD Million)
  • TABLE 99 Asia Pacific clinical trials market size, by country, 2021- 2027 (USD Million)
  • TABLE 100 Asia Pacific clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 101 Asia Pacific clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 102 Asia Pacific clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 103 Asia Pacific clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 104 Asia Pacific clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 105 Asia Pacific clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 106 Japan clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 107 Japan clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 108 Japan clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 109 Japan clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 110 Japan clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 111 Japan clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 112 China clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 113 China clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 114 China clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 115 China clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 116 China clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 117 China clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 118 India clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 119 India clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 120 India clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 121 India clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 122 India clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 123 India clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 124 Australia clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 125 Australia clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 126 Australia clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 127 Australia clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 128 Australia clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 129 Australia clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 130 Singapore clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 131 Singapore clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 132 Singapore clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 133 Singapore clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 134 Singapore clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 135 Singapore clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 136 Malaysia clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 137 Malaysia Clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 138 Malaysia clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 139 Malaysia clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 140 Malaysia clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 141 Malaysia clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 142 Indonesia clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 143 Indonesia Clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 144 Indonesia clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 145 Indonesia clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 146 Indonesia clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 147 Indonesia clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 148 Thailand clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 149 Thailand Clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 150 Thailand clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 151 Thailand clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 152 Thailand clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 153 Thailand clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 154 South Korea clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 155 South Korea Clinical Trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 156 South Korea clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 157 South Korea clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 158 South Korea clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 159 South Korea clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 160 Philippines clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 161 Philippines Clinical Trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 162 Philippines clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 163 Philippines clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 164 Philippines clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 165 Philippines clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 166 Latin America clinical trials market size, by country, 2016 - 2020 (USD Million)
  • TABLE 167 Latin America clinical trials market size, by country, 2021- 2027 (USD Million)
  • TABLE 168 Latin America clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 169 Latin America clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 170 Latin America clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 171 Latin America clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 172 Latin America clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 173 Latin America clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 174 Brazil clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 175 Brazil Clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 176 Brazil clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 177 Brazil clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 178 Brazil clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 179 Brazil clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 180 Mexico clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 181 Mexico Clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 182 Mexico clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 183 Mexico clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 184 Mexico clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 185 Mexico clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 186 MEA clinical trials market size, by country, 2016 - 2020 (USD Million)
  • TABLE 187 MEA clinical trials market size, by country, 2021- 2027 (USD Million)
  • TABLE 188 MEA clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 189 MEA clinical trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 190 MEA clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 191 MEA clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 192 MEA clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 193 MEA clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 194 South Africa clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 195 South Africa Clinical Trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 196 South Africa clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 197 South Africa clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 198 South Africa clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 199 South Africa clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)
  • TABLE 200 Saudi Arabia clinical trials market size, by phases, 2016 - 2020 (USD Mn)
  • TABLE 201 Saudi Arabia Clinical Trials market size, by phases, 2021- 2027 (USD Mn)
  • TABLE 202 Saudi Arabia clinical trials market size, by study design, 2016 - 2020 (USD Mn)
  • TABLE 203 Saudi Arabia clinical trials market size, by study design, 2021- 2027 (USD Mn)
  • TABLE 204 Saudi Arabia clinical trials market size, by therapeutic area, 2016 - 2020 (USD Mn)
  • TABLE 205 Saudi Arabia clinical trials market size, by therapeutic area, 2021- 2027 (USD Mn)

Charts & Figures

  • FIG. 1 Top-down approach
  • FIG. 2 Breakdown of primary participants
  • FIG. 3 Clinical trials industry, 360 degree synopsis, 2016-2027
  • FIG. 4 Industry segmentation
  • FIG. 5 Global clinical trials market, 2016 - 2027 (USD Million)
  • FIG. 6 Growth potential analysis, by phases
  • FIG. 7 Growth potential analysis, by study design
  • FIG. 8 Growth potential analysis, by therapeutic area
  • FIG. 9 Porter's analysis
  • FIG. 10 Company matrix analysis, 2020
  • FIG. 11 PESTEL analysis
  • FIG. 12 Key segment trends, by phases
  • FIG. 13 Key segment trends, by study design
  • FIG. 14 Key segment trends, by therapeutic area
  • FIG. 15 Key regional trends
  • FIG. 16 Competitive dashboard, 2020
目次
Product Code: 5029

The clinical trials market is projected to gain massive momentum in the decades to come owing to rising prevalence of chronic diseases, growing FDA regulations, and ongoing efforts towards discovering new treatments for various diseases. Clinical trials are a kind of research that thoroughly studies novel tests as well as treatments to evaluate their effects on the human health results.

These studies are usually performed to find more better ways to stop, screen for, treat or diagnose a disease. These trials might also exhibit which medical approaches might work best for certain group of people or illnesses. Clinical trials are also known to produce top-quality data for healthcare decision making.

The clinical trials market is segmented in terms of phases, study design, therapeutic area, and regional landscape.

Based on phases, the clinical trials market is categorized into phase IV, phase III, phase II, and phases I. In 2020, the phase IV segment accounted for more than $7.9 billion and is anticipated to progress at rapid pace over the projected period. A phase IV trial for medical devices or drugs usually takes place after a regulatory health authority, like the U.S. FDA (Food and Drug Administration) has given it its approval for use.

The effectiveness as well as safety of a drug or device are monitored in typically large, diverse populations. At times, the side effects of a drug might not become clear until and unless more individuals have taken it over a longer time period.

With respect to study design, the market for clinical trials is classified into expanded access study, observational study, and interventional study. Among these, the interventional study segment accounted for a market share of 77.4% in 2020 and will exhibit strong growth coming time.

These studies are often prospective and are particularly tailored to assess direct impacts of treatment or preventive measures on disease. Each of these study design has some specific outcome measures that depend on the type as well as the quality of data utilized.

In terms of therapeutic area, the overall clinical trials market is bifurcated into ophthalmology, dermatology, infectious disease, cardiology, oncology, autoimmune disease, and others. Ophthalmology segment is expected to reach a valuation of approximately $3.9 billion by the end of 2027.

From a regional frame of reference, in 2020, the Latin America clinical trials market accounted a market share of more than 3.8% and will exhibit a promising growth rate during the study period.

Meanwhile, Middle East & Africa is anticipated to show steady growth of 6.7% during the analysis time period.

Table of Contents

Chapter 1 Methodology

  • 1.1 Market definitions
  • 1.2 Base estimates & working
    • 1.2.1 North America
    • 1.2.2 Europe
    • 1.2.3 Asia Pacific
    • 1.2.4 Latin America
    • 1.2.5 Middle East & Africa
  • 1.3 Forecast parameters
  • 1.4 Data validation
  • 1.5 Data Sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Clinical trials industry 360 degree synopsis, 2016 - 2027
    • 2.1.1 Business trends
    • 2.1.2 Phases trends
    • 2.1.3 Study design
    • 2.1.4 Therapeutic area trends
    • 2.1.5 Regional trends

Chapter 3 Clinical Trials Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2016 - 2027
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Rise in government funding for clinical trials
      • 3.3.1.2 Growing demand for outsourcing clinical trials to CROs
      • 3.3.1.3 Increasing R&D expenditure
      • 3.3.1.4 Opportunities for conducting clinical trials in Asian countries
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 Regulatory complications in Asia Pacific region
      • 3.3.2.2 Infrastructural barriers in developing countries
  • 3.4 Growth potential analysis
    • 3.4.1 By phases
    • 3.4.2 By study design
    • 3.4.3 By therapeutic area
  • 3.5 COVID-19 impact analysis
  • 3.6 Porter's analysis
  • 3.7 Competitive landscape, 2020
    • 3.7.1 Company matrix analysis
  • 3.8 PESTEL analysis

Chapter 4 Clinical Trials Market, By Phase

  • 4.1 Key segment trend
  • 4.2 Phase I
    • 4.2.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.3 Phase II
    • 4.3.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.4 Phase III
    • 4.4.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.5 Phase IV
    • 4.5.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 5 Clinical Trials Market, By Study Design

  • 5.1 Key segment trend
  • 5.2 Interventional study
    • 5.2.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.3 Observational study
    • 5.3.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.4 Expanded access study
    • 5.4.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 6 Clinical Trials Market, By Therapeutic Area

  • 6.1 Key segment trend
  • 6.2 Autoimmune disease
    • 6.2.1 Market size, by region, 2016 - 2027 (USD Million)
  • 6.3 Oncology
    • 6.3.1 Market size, by region, 2016 - 2027 (USD Million)
  • 6.4 Cardiology
    • 6.4.1 Market size, by region, 2016 - 2027 (USD Million)
  • 6.5 Infectious disease
    • 6.5.1 Market size, by region, 2016 - 2027 (USD Million)
  • 6.6 Dermatology
    • 6.6.1 Market size, by region, 2016 - 2027 (USD Million)
  • 6.7 Ophthalmology
    • 6.7.1 Market size, by region, 2016 - 2027 (USD Million)
  • 6.8 Others
    • 6.8.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 7 Clinical Trials Market, By Region

  • 7.1 Key regional trends
  • 7.2 North America
    • 7.2.1 Market size, by country, 2016 - 2027 (USD Million)
    • 7.2.2 Market size, by phases, 2016 - 2027 (USD Million)
    • 7.2.3 Market size, by study design, 2016 - 2027 (USD Million)
    • 7.2.4 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.2.5 U.S.
      • 7.2.5.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.2.5.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.2.5.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.2.6 Canada
      • 7.2.6.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.2.6.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.2.6.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
  • 7.3 Europe
    • 7.3.1 Market size, by country, 2016 - 2027 (USD Million)
    • 7.3.2 Market size, by phases, 2016 - 2027 (USD Million)
    • 7.3.3 Market size, by study design, 2016 - 2027 (USD Million)
    • 7.3.4 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.3.5 Germany
      • 7.3.5.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.3.5.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.3.5.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.3.6 UK
      • 7.3.6.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.3.6.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.3.6.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.3.7 France
      • 7.3.7.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.3.7.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.3.7.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.3.8 Spain
      • 7.3.8.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.3.8.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.3.8.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.3.9 Italy
      • 7.3.9.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.3.9.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.3.9.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Market size, by country, 2016 - 2027 (USD Million)
    • 7.4.2 Market size, by phases, 2016 - 2027 (USD Million)
    • 7.4.3 Market size, by study design, 2016 - 2027 (USD Million)
    • 7.4.4 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.4.5 China
      • 7.4.5.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.4.5.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.4.5.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.4.6 Japan
      • 7.4.6.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.4.6.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.4.6.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.4.7 India
      • 7.4.7.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.4.7.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.4.7.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.4.8 Australia
      • 7.4.8.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.4.8.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.4.8.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.4.9 South Korea
      • 7.4.9.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.4.9.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.4.9.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.4.10 Singapore
      • 7.4.10.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.4.10.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.4.10.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.4.11 Malaysia
      • 7.4.11.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.4.11.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.4.11.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.4.12 Indonesia
      • 7.4.12.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.4.12.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.4.12.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.4.13 Thailand
      • 7.4.13.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.4.13.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.4.13.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.4.14 Philippines
      • 7.4.14.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.4.14.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.4.14.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Market size, by country, 2016 - 2027 (USD Million)
    • 7.5.2 Market size, by phases, 2016 - 2027 (USD Million)
    • 7.5.3 Market size, by study design, 2016 - 2027 (USD Million)
    • 7.5.4 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.5.5 Brazil
      • 7.5.5.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.5.5.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.5.5.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.5.6 Mexico
      • 7.5.6.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.5.6.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.5.6.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
  • 7.6 Middle East and Africa
    • 7.6.1 Market size, by country, 2016 - 2027 (USD Million)
    • 7.6.2 Market size, by phases, 2016 - 2027 (USD Million)
    • 7.6.3 Market size, by study design, 2016 - 2027 (USD Million)
    • 7.6.4 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.6.5 South Africa
      • 7.6.5.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.6.5.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.6.5.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)
    • 7.6.6 Saudi Arabia
      • 7.6.6.1 Market size, by phases, 2016 - 2027 (USD Million)
      • 7.6.6.2 Market size, by study design, 2016 - 2027 (USD Million)
      • 7.6.6.3 Market size, by therapeutic area, 2016 - 2027 (USD Million)

Chapter 8 Company Profiles

  • 8.1 Competitive dashboard
  • 8.2 Bioclinica
    • 8.2.1 Business overview
    • 8.2.2 Financial data
    • 8.2.3 Product landscape
    • 8.2.4 Strategic outlook
    • 8.2.5 SWOT analysis
  • 8.3 ICON plc
    • 8.3.1 Business overview
    • 8.3.2 Financial data
    • 8.3.3 Product landscape
    • 8.3.4 Strategic outlook
    • 8.3.5 SWOT analysis
  • 8.4 Laboratory Corporation of American Holding (Covance Inc)
    • 8.4.1 Business overview
    • 8.4.2 Financial data
    • 8.4.3 Product landscape
    • 8.4.4 Strategic outlook
    • 8.4.5 SWOT analysis
  • 8.5 Medpace, Inc
    • 8.5.1 Business overview
    • 8.5.2 Financial data
    • 8.5.3 Product landscape
    • 8.5.4 Strategic outlook
    • 8.5.5 SWOT analysis
  • 8.6 Pharmaceutical Product Development, LLC (PPD)
    • 8.6.1 Business overview
    • 8.6.2 Financial data
    • 8.6.3 Product landscape
    • 8.6.4 Strategic outlook
    • 8.6.5 SWOT analysis
  • 8.7 PRA Health Sciences
    • 8.7.1 Business overview
    • 8.7.2 Financial data
    • 8.7.3 Product landscape
    • 8.7.4 Strategic outlook
    • 8.7.5 SWOT analysis
  • 8.8 WuXi AppTec
    • 8.8.1 Business overview
    • 8.8.2 Financial data
    • 8.8.3 Product landscape
    • 8.8.4 Strategic outlook
    • 8.8.5 SWOT analysis
  • 8.9 Parexel International Corporation
    • 8.9.1 Business overview
    • 8.9.2 Financial data
    • 8.9.3 Product landscape
    • 8.9.4 Strategic outlook
    • 8.9.5 SWOT analysis
  • 8.10 Charles River Laboratories (MPI Research)
    • 8.10.1 Business overview
    • 8.10.2 Financial data
    • 8.10.3 Product landscape
    • 8.10.4 Strategic outlook
    • 8.10.5 SWOT analysis
  • 8.11 Apex Medical Research
    • 8.11.1 Business overview
    • 8.11.2 Financial data
    • 8.11.3 Product landscape
    • 8.11.4 Strategic outlook
    • 8.11.5 SWOT analysis
  • 8.12 IQVIA
    • 8.12.1 Business overview
    • 8.12.2 Financial data
    • 8.12.3 Product landscape
    • 8.12.4 Strategic outlook
    • 8.12.5 SWOT analysis
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.